Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
- PMID: 35362873
- PMCID: PMC8972669
- DOI: 10.1186/s13613-022-01007-7
Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
Figures

Erratum for
-
Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.Ann Intensive Care. 2022 Mar 5;12(1):21. doi: 10.1186/s13613-022-00982-1. Ann Intensive Care. 2022. PMID: 35246776 Free PMC article.
References
-
- Bidar F, Hamada S, Gossez M, Coudereau R, Lopez J, Cazalis M-A, Tardiveau C, Brengel-Pesce K, Mommert M, Buisson M, Conti F, Rimmelé T, Lukaszewicz A-C, Argaud L, Cour M, Monneret G, Venet F. Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients, for the RICO study group. Ann Intensive Care. 2022;12:21. doi: 10.1186/s13613-022-00982-1. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources